Alps Advisors Inc Inmune Bio, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$5.48 - $8.97 $100,629 - $164,716	-18,363 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.42 - $11.39 $14,682 - $26,048	-2,287 Reduced 11.08%	18,363 $155,000
Q4 2021 Feb 09, 2022	SELL	$9.97 - $20.38 $10,458 - $21,378	-1,049 Reduced 4.83%	20,650 $211,000
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $28,768 - $56,702	2,036 Added 10.35%	21,699 $421,000
Q2 2021 Aug 11, 2021	BUY	$9.29 - $19.33 $182,669 - $380,085	19,663 New	19,663 $345,000

2.88M

44.6K

3.5K

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $145M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.